Note*: This report requires 5-10 business days to complete.
“Pulmonary Arterial Hypertension (PAH) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Pulmonary Arterial Hypertension (PAH) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Pulmonary Arterial Hypertension (PAH) from 2010-2020.Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. About 50 percent of people who have been diagnosed with PAH will die from the disease within five years. Treatment can extend life expectancy, but people diagnosed with PAH who don’t receive adequate treatment live an average of three years. It is expected that in the near future some of these potential therapeutic options can be utilized in combination with established pharmacologic therapies to treat PAH aggressively by targeting multiple effectors pathways, thereby offering both symptomatic and survival benefits to the sufferers of this progressively fatal disease.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Pulmonary Arterial Hypertension (PAH) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Pulmonary Arterial Hypertension (PAH)
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Pulmonary Arterial Hypertension (PAH) Market
• Global Epidemiology of Pulmonary Arterial Hypertension (PAH) Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Pulmonary Arterial Hypertension (PAH) Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Pulmonary Arterial Hypertension (PAH) (2011-2020)
• Table 7: Pulmonary Arterial Hypertension (PAH) Global Market Size (USD Millions), (2011-2014)
• Table 8: Pulmonary Arterial Hypertension (PAH) Global Market Size (USD Millions), (2015-2020)
• Table 9: Pulmonary Arterial Hypertension (PAH) US Market Size (USD Millions), (2011-2014)
• Table 10: Pulmonary Arterial Hypertension (PAH) US Market Size (USD Millions), (2015-2020)
• Table 11: Pulmonary Arterial Hypertension (PAH) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Pulmonary Arterial Hypertension (PAH) Germany Market Size (USD Millions), (2015-2020)
• Table 13: Pulmonary Arterial Hypertension (PAH) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Pulmonary Arterial Hypertension (PAH) United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Pulmonary Arterial Hypertension (PAH) France Market Size (USD Millions), (2011-2014)
• Table 16: Pulmonary Arterial Hypertension (PAH) France Market Size (USD Millions), (2015-2020)
• Table 17: Pulmonary Arterial Hypertension (PAH) Italy Market Size (USD Millions), (2011-2014)
• Table 18: Pulmonary Arterial Hypertension (PAH) Italy Market Size (USD Millions), (2015-2020)
• Table 19: Pulmonary Arterial Hypertension (PAH) Spain Market Size (USD Millions), (2011-2014)
• Table 20: Pulmonary Arterial Hypertension (PAH) Spain Market Size (USD Millions), (2015-2020)
• Table 21: Pulmonary Arterial Hypertension (PAH) Japan Market Size (USD Millions), (2011-2014)
• Table 22: Pulmonary Arterial Hypertension (PAH) Japan Market Size (USD Millions), (2015-2020)
• Table 23: Pulmonary Arterial Hypertension (PAH) ROW Market Size (USD Millions), (2011-2014)
• Table 24: Pulmonary Arterial Hypertension (PAH) ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Pulmonary Arterial Hypertension (PAH) Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Pulmonary Arterial Hypertension (PAH) (2011-2020)
• Figure 3: Pulmonary Arterial Hypertension (PAH) Global Market Size (USD Millions), (2011-2014)
• Figure 4: Pulmonary Arterial Hypertension (PAH) Global Market Size (USD Millions), (2015-2020)
• Figure 5: Pulmonary Arterial Hypertension (PAH) US Market Size (USD Millions), (2011-2014)
• Figure 6: Pulmonary Arterial Hypertension (PAH) US Market Size (USD Millions), (2015-2020)
• Figure 7: Pulmonary Arterial Hypertension (PAH) Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Pulmonary Arterial Hypertension (PAH) Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Pulmonary Arterial Hypertension (PAH) United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Pulmonary Arterial Hypertension (PAH) United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Pulmonary Arterial Hypertension (PAH) France Market Size (USD Millions), (2011-2014)
• Figure 12: Pulmonary Arterial Hypertension (PAH) France Market Size (USD Millions), (2015-2020)
• Figure 13: Pulmonary Arterial Hypertension (PAH) Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Pulmonary Arterial Hypertension (PAH) Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Pulmonary Arterial Hypertension (PAH) Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Pulmonary Arterial Hypertension (PAH) Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Pulmonary Arterial Hypertension (PAH) Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Pulmonary Arterial Hypertension (PAH) Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Pulmonary Arterial Hypertension (PAH) ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Pulmonary Arterial Hypertension (PAH) ROW Market Size (USD Millions), (2015-2020)
